Sponsor: BioNTech Pharmaceuticals
Sponsor Study ID: BNT-122-01
Study Title: A Phase II Clinical Trial Comparing the Efficacy of RO7198457 Versus Watchful Waiting in Patients With ctDNA Positive, Resected Stage II (High Risk) and Stage III Colorectal Cancer
CTO #: 103669
NCT Number: NCT04486378
Phase: II
Protocol Type: Treatment
Age Group: Adults
Disease Sites: Colon
Study Objectives: To demonstrate superiority of RO7198457 compared to watchful waiting in terms of DFS in chemotherapy pre-treated patients.